“…The gapmer ASOs (ASO 1-12) were prepared by automated oligonucleotide synthesis using commercial DNA and LNA phosphoramidites and palmitoyl-and myristoyl-amino-LNA phosphoramidites using standard methods for oligonucleotide synthesis, workup, purification, and isolation with minor modifications as published for oligonucleotides containing palmitoyl-amino-LNA nucleotide monomers. 34 Sequences of all ASOs are listed: ASO 1: 5 0 -TAGcctgtcactt CTC-3 0 , ASO 2: 5 0 -PAGcctgtcacttCTC-3 0 , ASO 3: 5 0 -PAGcctgtcactt CPC-3 0 , ASO 4: 5 0 -TAGcctgtcacttCPP*-3 0 , ASO 5: 5 0 -MAGcctgtcactt CTC-3 0 , ASO 6: 5 0 -MAGcctgtcacttCMC-3 0 , ASO 7: 5 0 -TAGcctgt cacttCTC-3 0 , ASO 8: 5 0 -PAGcctgtcacttCTC-3 0 , ASO 9: 5 0 -PAGcctgtca cttCPC3-3 0 , ASO 10: 5 0 -TAGcctgtcacttCPP*-3 0 , ASO 11: 5 0 -MAG cctgtcacttCTC-3 0 , ASO 12: 5 0 -MAGcctgtcacttCMC-3 0 . P and M denote palmitoyl-amino-LNA and myristoyl-amino-LNA thymine monomers, respectively; P* and M* denote palmitoyl-amino-LNA and myristoyl-amino-LNA 5-methyl-cytosine monomers, respectively; A, C, G, and T denote LNA monomers, and a, c, g, and t denote DNA monomers.…”